balanc risk/reward pullback
upgrad neutral
valuat normal miss upgrad neutral
uncharacterist miss result adj ebitda come
consensu compani price perfect forward ebitda top
histor rang stock sold approx sinc near-term peak
juli day earn releas vs compani
trade ebitda estim see balanc risk/reward
particularli given hca track record react short-term swing volumes/mix
although bear case less clear sell-off bull case still seem difficult
make given near term polit headlin risk long-term structur
headwind volum payer mix upgrad neutral under-perform
reflect view appropri risk/reward rais po
ebitda estimate view like
address mix/earn shortfal faster street expect
guidanc reason track record respond issu
compani attribut miss weaker expect commerci volum
quarter particularli inpati surgeri although total volum solid lower
mix impact revenu per admiss caus neg fix cost leverag despit
miss compani rais low end full year adj ebitda guidanc
essenti updat outlook perform strong weak
despit guidanc rais season achiev slightli higher
percentag full year ebitda achiev first half past
year number still look reason view time believ
like rebound issu volum bounc around
quarter would surpris see commerci volum rebound
like respond lower revenu cost offset allow hit
ebitda target addit estim medicar dsh updat would
add ebitda provid cushion growth
signific cash balanc sheet market cap
expect continu deploy cash along aggress
share repurchas deal steadi stream tuck-in deal wait next
deal size would creat nice supplement low singl digit organ ebitda growth
alreadi seen year polit headlin pressur multipl
attent medicar surpris bill price transpar legisl
put pressur stock certain point year meanwhil afford
act court challeng could creat volatil sept/oct appel court
uphold rule overhang could persist mid-year
suprem court hear case time see structur
pressur volum growth shift lower cost set payer mix popul
growth cohort per year next year
persist would like exacerb economi slow
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
po base ebitda near midpoint histor
multipl rang hospit fundament appear steadi near medium term
aid strong economi compani continu deploy signific
amount capit share repo deal
risk upsid histori aggress control cost tough
oper environ compani track record put strong
balanc sheet work
risk downsid commerci volum soft caus anoth adj ebitda
miss compani come low end full year guidanc
headlin risk around medicar neg rule constitution
potenti legisl surpris bill transpar could creat volatil
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
invest opinion system contain end report head fundament equiti opinion dark grey shade indic secur restrict opinion suspend medium grey
shade indic secur review opinion withdrawn grey shade indic secur cover chart current juli later date indic
equiti invest rate distribut health group jun
equiti invest rate distribut global group jun
issuer invest bank client bofa merril lynch one affili within past month purpos invest rate distribut coverag univers includ stock
stock rate neutral includ hold stock rate under-perform includ sell
price fluctuat medium high invest rate reflect analyst assess stock absolut total return potenti ii
attract invest rel stock within coverag cluster defin three invest rate buy stock expect total
return least attract stock coverag cluster neutral stock expect remain flat increas valu less attract
buy rate stock under-perform stock least attract stock coverag cluster analyst assign invest rate consid among thing
month total return expect stock firm guidelin rate dispers shown tabl current price object stock
referenc better understand total return expect given time price object reflect analyst view potenti price appreci depreci
fundament equiti opinion opinion includ volatil risk rate invest rate incom rate volatil risk rate indic potenti
total return expect within period date initi rate
rate dispers guidelin coverag cluster
rate dispers may vari time time bofa merril lynch research believ better reflect invest prospect stock coverag cluster
incom rate indic potenti cash dividend same/high dividend consid secur same/low dividend consid secur pay
cash dividend coverag cluster compris stock cover singl analyst two analyst share common industri sector region classif stock
coverag cluster includ recent bofa merril lynch report referenc stock
price chart secur referenc research report avail http //pricechart baml com call mail
bofa one affili act market maker equiti secur recommend report
issuer within last month invest bank client bofa and/or one affili
bofa affili receiv compens issuer non-invest bank servic product within past month
issuer within last month non-secur busi client bofa and/or one affili
bofa affili receiv compens invest bank servic issuer within past month
bofa affili expect receiv intend seek compens invest bank servic issuer affili issuer within next three month
bofa one affili will sell buy client common equiti issuer princip basi
issuer within last month secur busi client non-invest bank bofa and/or one affili
bofa merril lynch research personnel includ analyst respons report receiv compens base upon among factor overal profit america
corpor includ profit deriv invest bank analyst respons report may also receiv compens base upon among factor overal
profit bank sale trade busi relat class secur financi instrument analyst respons
